Elutia (ELUT) Cash from Operations (2019 - 2026)
Elutia (ELUT) reported Cash from Operations of 7800000.0 for Q1 2026, up 12.17% on a YoY basis from 6953603.69 in Q1 2025, and up 68.56% sequentially from 24810000.0 in Q4 2025.
Elutia (ELUT) Cash from Operations (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Cash from Operations data on file, last reported at 7800000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 12.17% year-over-year to 7800000.0; the trailing twelve-month figure through Mar 2026 stood at 43729000.0 (down 51.33% YoY), and the FY2025 full-year result was 44810000.0, down 97.78% from the prior year.
- Cash from Operations advanced to 7800000.0 in Q1 2026, from 24810000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2389000.0 in Q2 2023 to a low of 24810000.0 in Q4 2025.
- A 5-year average of 7402235.29 and a median of 5515000.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 1259.59% in 2022 and soared 77.67% in 2023, its largest moves.
- Tracing ELUT's Cash from Operations over 5 years: stood at 5245000.0 in 2022, then tumbled by 73.17% to 9083000.0 in 2023, then tumbled by 34.94% to 12257000.0 in 2024, then tumbled by 102.41% to 24810000.0 in 2025, then soared by 68.56% to 7800000.0 in 2026.
- Business Quant data shows ELUT's Cash from Operations at 7800000.0 in Q1 2026, 24810000.0 in Q4 2025, and 2900000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | -7.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.80 Mn |
| Mar 31, 2026 | -7.80 Mn |
| Dec 31, 2025 | -24.81 Mn |
| Dec 31, 2025 | -24.81 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Jun 30, 2025 | -8.22 Mn |
| Jun 30, 2025 | -8.22 Mn |
| Mar 31, 2025 | -8.88 Mn |
| Mar 31, 2025 | -8.88 Mn |
| Dec 31, 2024 | -12.26 Mn |
| Dec 31, 2024 | -12.26 Mn |
| Sep 30, 2024 | -3.43 Mn |
| Sep 30, 2024 | -3.43 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Dec 31, 2023 | -9.08 Mn |
| Dec 31, 2023 | -9.08 Mn |